FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Williams Gregg
   2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [VANI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
13170 TELFAIR AVENUE		 3. Date of Earliest Transaction (Month/Day/Year)
08/30/2022
(Street)

SYLMAR, CA 91342		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/30/2022   J(1)   7,891,098 A $ 0 11,636,814 I See footnote (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 03/03/2025 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   423,669   08/30/2022 10/23/2023 common stock 423,669 $ 0 423,669 I Trust
Warrant $ 3.147 08/30/2022   J(2)   158,875   08/30/2022 03/18/2024 common stock 158,875 $ 0 158,875 I Trust
Warrant $ 3.147 08/30/2022   J(2)   476,631   08/30/2022 04/15/2024 common stock 476,631 $ 0 476,631 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 07/02/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 07/31/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 09/03/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 10/01/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 11/04/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 12/03/2024 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 01/02/2025 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 01/31/2025 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   190,650   08/30/2022 04/01/2025 common stock 190,650 $ 0 190,650 I Trust
Warrant $ 3.147 08/30/2022   J(2)   127,097   08/30/2022 06/03/2025 common stock 127,097 $ 0 127,097 I Trust
Warrant $ 3.147 08/30/2022   J(2)   127,097   08/30/2022 07/01/2025 common stock 127,097 $ 0 127,097 I Trust
Warrant $ 3.147 08/30/2022   J(2)   127,097   08/30/2022 08/31/2025 common stock 127,097 $ 0 127,097 I Trust
Warrant $ 3.147 08/30/2022   J(2)   60,530   08/30/2022 10/02/2025 common stock 60,530 $ 0 60,530 I Trust
Warrant $ 3.147 08/30/2022   J(2)   79,505   08/30/2022 12/07/2025 common stock 79,505 $ 0 79,505 I Trust
Warrant $ 3.147 08/30/2022   J(2)   109,623   08/30/2022 12/08/2025 common stock 109,623 $ 0 109,623 I Trust
Warrant $ 3.147 08/30/2022   J(2)   317,753   08/30/2022 02/23/2026 common stock 317,753 $ 0 317,753 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 03/31/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 05/24/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 06/30/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 07/23/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 08/27/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 09/29/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   329,891   08/30/2022 10/29/2026 common stock 329,891 $ 0 329,891 I Trust
Warrant $ 3.147 08/30/2022   J(2)   506,797   08/30/2022 11/29/2026 common stock 506,797 $ 0 506,797 I Trust
Warrant $ 3.147 08/30/2022   J(2)   506,794   08/30/2022 12/28/2026 common stock 506,794 $ 0 506,794 I Trust

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Williams Gregg
13170 TELFAIR AVENUE
SYLMAR, CA 91342		   X   X    

Signatures

 /s/ Gregg Williams   09/01/2022
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated on August 30, 2022.
(2) Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022.
(3) After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 9,511,062 shares of common stock and warrants to purchase 7,808,405 shares of common stock owned by GW Trust, (ii) 1,212,856 shares of common stock and warrants to purchase 1,151,012 shares of common stock owned by Williams International Co. LLC (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 731,309 shares of common stock and warrants to purchase 287,753 shares of common stock owned by GST. Greg Williams has voting and dispositive power over all of these shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.